‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight
We’re learning more about the super-effective “triple-G” weight loss drug retatrutide. The drug, the first of its kind to target three metabolic receptors (GLP-1, GIP, and glucagon), is nearing the end of clinical trials and is expected to be submitted to the FDA for approval early next year. People are already clamoring to get their … Read more